Showing results (2421-2430 of 2,656) with videos related to
Sort By:
Pageof 266
Journal of Clinical Epidemiology|March 31, 2015
WHO/ISH total risk approach for primary prevention of cardiovascular disease shows greater decrease in costs for women but not the elderly in JamaicaAbdullahi O Abdulkadri, Marshall K Tulloch-Reid, Damian K Francis, et al.Biomacromolecules|July 28, 2016
Application of Targeted Molecular and Material Property Optimization to Bacterial Attachment-Resistant (Meth)acrylate PolymersKevin Adlington, Nam T Nguyen, Elizabeth Eaves, et al.Human Gene Therapy|August 28, 1998
Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigenM Sällberg, J Hughes, A Javadian, et al.Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progressionDou Yu, Omar F Khan, Mario L Suvà, et al.Sleep Medicine|October 17, 2017
Sleep and cognitive performance: cross-sectional associations in the UK BiobankSimon D Kyle, Claire E Sexton, Bernd Feige, et al.Molecular Cancer Therapeutics|August 28, 2020
Targeting Multiple EGFR-expressing Tumors with a Highly Potent Tumor-selective Antibody-Drug ConjugateMark G Anderson, Hugh D Falls, Michael J Mitten, et al.Pharmacology|July 26, 2017
A "Prozone-Like" Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor ReceptorKedar S Vaidya, Anatol Oleksijew, Lora A Tucker, et al.Molecular Therapy. Nucleic Acids|December 20, 2019
In Vivo RNAi-Mediated eIF3m Knockdown Affects Ribosome Biogenesis and Transcription but Has Limited Impact on mRNA-Specific TranslationElena M Smekalova, Maxim V Gerashchenko, Patrick B F O'Connor, et al.Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Small RNA combination therapy for lung cancerWen Xue, James E Dahlman, Tuomas Tammela, et al.Science Signaling|May 30, 2023
The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regenerationCoenraad Frederik Slabber, Marc Bachofner, Tobias Speicher, et al.Pageof 266